2011-05-13T14:32:44-05:00 2010-06-30 Metcalf Davis CPAs 3340 Peachtree Road NE Suite 2600 Atlanta GA 303261089 990 2009-07-01 582106707 National Foundation for the Centers for Disease Control and Prevention Inc NATI 4046530790 55 Park Place No 400 Atlanta GA 30303 Charles Stokes 4046530790 2011-05-13 1 Susan Hill 4042641700 2011-05-12 2009 2016-02-24 21:20:13Z CDC Foundation Charles Stokes 55 Park Place No 400 Atlanta GA 30303 23549295 0 X www.cdcfoundation.org X 1993 GA See Schedule O The CDC Foundation helps the Centers for Disease Control and Prevention (CDC) do more, faster, by forging effective partnerships between CDC and corporations, foundations, organizations and individuals to fight threats to health and safety. 17 17 42 23 0 0 56406274 22096581 849646 795748 340022 58713 0 57595942 22951042 14942908 11607704 0 2673048 3373676 0 1316837 12888285 11325541 30504241 26306921 27091701 -3355879 76851023 74521205 12689140 13405719 64161883 61115486 The CDC Foundation helps the Centers for Disease Control and Prevention (CDC) do more, faster by forging effective partnerships between CDC and others to fight threats to health and safety. 0 0 7310448 4840348 Bloomberg Initiative to Reduce Tobacco Use See Schedule O for descriptionBloomberg Initiative to Reduce Tobacco Use Tobacco use is a major preventable cause of premature death and disease worldwide. Approximately 5.4 million people die each year due to tobacco-related illnesses-a figure expected to increase to more than 8 million a year by 2030. The vast majority of these deaths are projected to occur in the developing world.The Global Adult Tobacco Survey (GATS), helps countries monitor adult tobacco use, exposure to second-hand smoke, quit attempts and the effectiveness of tobacco control measures among adults. Data for the survey are collected through face-to-face interviews using electronic data collection.The goals of the CDC Foundation's Bloomberg Initiative to Reduce Tobacco Use are to implement the Global Adult Tobacco Survey (GATS); ensure the use of Tobacco Questions for Survey: A Subset of Key Questions from the GATS (TQS); and disseminate tobacco use data in various low-, middle-, and high-income countries throughout the world. To achieve these goals, the CDC Foundation collaborated with the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and various other partners. By the conclusion of the reporting period, all fourteen Phase 1 GATS countries completed the survey. Eight of these fourteen had also disseminated data collected from GATS. In addition to completing Phase 1 surveys, six new Phase 2 countries were identified for survey implementation, and the TQS was formally released to various global partners for inclusion into ongoing national/international surveys. 2802124 1501244 Strengthening Disease Surveillance and Response in Central AfricaSee Schedule O for descriptionStrengthening Disease Surveillance and Response in Central AfricaStrengthening Disease Surveillance and Response in Central Africa is a five-year surveillance demonstration on project within three selected countries of the Central African sub-region: Cameroon, the Democratic Republic of the Congo, and the Central African Republic. The countries were selected due to their epidemiologic importance related to disease outbreaks, emerging infections, and gaps in current surveillance. The goal of the project is to effectively use available resources to support in-country surveillance functions in order to yield reliable epidemiologic data for detecting, monitoring, and evaluating outbreaks, diseases, and resulting control activities. The goal of the project will be accomplished through three primary objectives: 1) strengthening surveillance and response capacity and quality through training and infrastructure improvements, 2) implementing a quality surveillance and response program for Vaccine Preventable Diseases/syndromes, including laboratory capacity, networks, and data management systems, and 3) strengthening communications infrastructure and developing capacity for advocacy to ensure these efforts are assumed by the Ministries of Health in the selected countries.From the project's inception in November of 2008 until September 2009, the primary objective was to support administrative functions necessary for developing strategies that would enable project partners to work collaboratively on accomplishing overall goals. Funds during this period primarily supported administrative function costs associated with the startup of the project. Pre- and full assessments of the three selected countries were also conducted during the initial eleven months of the project. Project activities for the period of October 2009 through September 2010 included the development and approval of a detailed Global Plan of Action and three Country Plans of Action that identify the project priorities and activities to be implemented in each selected country. Once the three Country Plans of Action were approved in March 2010, project implementation began. Ongoing activities such as project management team meetings, the selection and identification of various personnel and laboratory facilities, and the initiation of training courses for public health professionals occurred during this timeframe. 1694804 492822 Meta-Leadership InitiativeSee Schedule O for descriptionMeta-Leadership InitiativeThis funding period represents the second full year of the Meta-Leadership Initiative. The Meta-Leadership Initiative provides Meta-Leadership Summits for Preparedness across the country, with a focus on the largest Metropolitan Statistical Areas. Summits are thought-provoking learning and networking opportunities designed to create a national cadre of leaders in the business, government and nonprofit sectors who share the same vocabulary and approach to providing leadership in crisis situationsThrough participation in the Summit, leaders:-Learn to reach decisions in the face of uncertainty, fear and stress. -Practice skills and behaviors necessary for effective action in times of crisis. -Gain the confidence needed to lead up and across organizational lines. -Identify partnerships that can be leveraged before, during and after a crisis. -Become part of a network of individuals committed to enhancing community readiness for an emergency.Eleven Summits were held during this period, serving approximately 1,500 local leaders:-Lexington, Kentucky, October 2009-North Carolina, November 2009-Minneapolis, Minnesota, November 2009-Coastal Georgia, December 2009-Atlanta, Georgia, February 2010-Phoenix, Arizona, February 2010-St. Louis, Missouri, March 2010-New Mexico, April 2010-Columbus, Ohio, May 2010-Southeastern Louisiana, June 2010-California (state level) , June 2010Much of the planning for the first eight of the fifteen summits for Phase 2C was accomplished during this reporting period as well. In addition, the Post Summit Activity phase for the previous nine summits (2008-2009 year) and several of those listed above were completed. After each Summit, a dedicated CDC team works with state and local leaders to organize a post-summit activity to continue the momentum of meta-leadership efforts begun at the Summit. The activity, offered within three to six months of the Summit, reconvenes participants and other community leaders, addresses preparedness gaps identified at the Summit and is unique to each community's needs.Immediate evaluation results demonstrate that 93% of respondents report the Summit as a valuable use of their time and 88% intend to apply what they've learned to their work. Intermediate evaluations reveal that 85% of respondents actually do use meta-leadership concepts or principles after the Summit; of these, 94% reported that practicing meta-leadership has made a positive difference for them or their organization. 11010710 4773290 795748 The Foundation, working in collaboration with the CDC, spends the vast majority of its funds directly for programs and projects that further its exempt purposes. These disbursements are either in the form of grants or awards or in the form of fees for services. In addition to the programs mentioned in detail on Schedule O, the Foundation manages a variety of programs that include such things as chronic health and infectious diseases, global health priorities such as safe water and programs for environmental health and occupational health and safety. 11010710 4773290 795748 22818086 1 1 0 0 0 0 0 0 1 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 156 0 1 42 1 0 0 0 0 0 0 0 0 0 0 0 17 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 1 0 AL AK AZ AR CA CT DC FL GA IL KS KY LA ME MD MA MI MN MS MO NE NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X Kelley Mouchabeck 4046530790 55 Park Place Suite 400 Atlanta GA 303032915 Andrew Klepchick 2.00 X X 0 0 0 Philip Jacobs 4.00 X X 0 0 0 Ruth Katz 0.70 X X 0 0 0 Charles Pete McTier 0.80 X 0 0 0 David Ratcliff 0.30 X 0 0 0 David Satcher MD 0.10 X 0 0 0 Donald R Hopkins MD 0.50 X 0 0 0 Douglas Nelson 0.20 X 0 0 0 Gary Cohen 1.40 X 0 0 0 James Hagedorn 0.10 X 0 0 0 Jim Down 0.50 X 0 0 0 Marni Vliet 0.70 X 0 0 0 Michele Hooper 0.20 X 0 0 0 Robert Jeffrey 0.70 X 0 0 0 Robert Yellowlees 0.90 X 0 0 0 Amy Robbins 0.20 X 0 0 0 Colleen Goggins 0.10 X 0 0 0 Charles Stokes 60.00 X 256427 0 53300 Kelley T Mouchabeck 35.00 X 126970 0 17500 Chloe Tonney 55.00 X X 167967 0 25500 William Parra 55.00 X 118110 0 18100 Kathryn Ruddon 32.00 X 104770 0 15300 774244 0 129700 5 0 1 0 Macro International Inc 15292 Collection Center Drive Chicago IL 60693 Childhood Obesity Assessment/Prevention. 630780 Voxiva Inc 1990 K Street NW Suite 400 Washington DC 20006 Professional Fees - Phones for Health. 545486 Science Applications International Corporation PO Box 2 Pittsburgh PA 152512058 Professional Fees - Freedom from Smoking 456962 Center for Health Services Research Henry Ford Health System One Ford Detroit MI 48202 Chronic Hepatitis Study 418159 McKing Consulting Corporation 2810 Old Lee Highway Suite 300 Fairfax VA 220314376 Professional Fees - Freedom from Smoking 327287 19 3043334 19053247 112330 22096581 Data Collect/Research 541700 417894 417894 Lab Research Agreement 541900 289210 289210 Health Training 611600 60590 60590 Health Surveillance 541900 28054 28054 795748 151940 151940 505026 598253 -93227 -93227 -93227 22951042 795748 0 58713 6389365 6389365 5218339 5218339 769383 66327 419838 283218 2042520 828408 675827 538285 185697 79526 59024 47147 216393 92362 68513 55518 159683 66810 52219 40654 63055 1191 59989 1875 44100 44100 380 380 7775032 7509759 258199 7074 22623 7863 14760 430948 184795 161329 84824 211547 58910 134558 18079 365142 177362 123085 64695 1185854 1065722 27836 92296 142485 142485 779433 691098 27062 61273 73515 28749 28338 16428 18371 1430 16941 Scientific Supplies 166801 166801 Miscellaneous 46255 40784 5471 26306921 22818086 2171998 1316837 X 34219739 45561395 36966771 26216193 438262 332679 3076623 137016 476396 269912 210093 206484 1939535 2067438 76851023 74521205 466588 684965 2311729 1996412 491308 421677 9419515 10302665 12689140 13405719 X 7008918 8247332 54785233 50427194 2367732 2440960 64161883 61115486 76851023 74521205 X 0 1 1 X 1 1 X 11674272 34471854 12606265 57288392 22096581 138137364 467896 613114 652091 498406 478546 2710053 12142168 35084968 13258356 57786798 22575127 140847417 77686507 63160910 706411 1068365 968876 355276 151940 3250868 144098285 1640662 0.43830 0.40490 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 767022 1000000 0 0 1767022 2650533 22691 14091 0 0 36782 191756 250000 0 0 441756 662634 0 1 1934568 112868 202929 187565 19121 2043679 2482206 62808 -469792 124074 16580 1934568 1.00000 0 0 31711 9187 22524 126558 108825 17733 318127 151900 166227 206484 Contracts Payable 5021273 Deferred rent 280166 Other liabilities 26250 Refundable advances 4974976 10302665 22951042 26306921 -3355879 309482 309482 -3046397 23739070 309482 478546 788028 22951042 0 22951042 26785467 478546 478546 26306921 0 26306921 Part IV, Line 2b: The funds held in custodial accounts are for CDC programs for conferences and management training courses. Part V, Line 4: Description of Intended Use of Endowment Funds: The endowment funds are used for programs such as a global health fellowships, scientific lectures, safe water and hospital based infections. Part X: Description of Uncertain Tax Positions Under FIN 48: Income Taxes - The Foundation is recognized as an organization which is exempt from federal income tax under Section 501(c)(3) of the Internal Revenue Code (the"Code") whereby only unrelated business income, as defined by Section 512(a)(1) of the code, is subject to federal income tax. The Foundation's policy is to record a liability for any tax position taken that is beneficial to the Foundation, including any related interest and penalties, when it is more likely than not the position taken by management with respect to a transaction or class of transactions will be overturned by a taxing authority upon examination. Management believes there are no such positions as of June 30, 2010 and 2009 and, accordingly, no liabilty has been accrued. Generally the IRS may examine a tax return for three years from the date it is filed. At June 30, 2010, tax years ended June 30, 2007, 2008 and 2009 remained open for possible examination by the IRS. Part X, Refundable Advances: During a prior year the Foundation received $5,000,000 in refundable advances to be used for Emergency Preparedness and Response which includes severe future national level emergencies. Recognition as revenue is contingent upon the Foundation using these funds for their intended purpose by November 14, 2011. At June 30, 2010 $4,974,976 remained available to be expended in future years. 0 Central America/Caribbean 0 0 Prog. Service Consulting 145560 East Asia and Pacific 0 0 Grantmaking 164348 East Asia and Pacific 0 0 Prog. Service Consulting 2950 East Asia and Pacific 0 0 Prog. Service Travel Reim. 34535 East Asia and Pacific 0 0 Prog. Service Supplies 81682 East Asia and Pacific 0 0 Prog. Service Conference 874 Europe 0 0 Grantmaking 4676799 Europe 0 0 Prog. Service Conference 93547 Europe 0 0 Prog. Service Consulting 236073 Europe 0 0 Prog. Service Travel Reim. 12199 Europe 0 0 Prog. Service Printing 41205 Europe 0 0 Prog. Service Supplies 148 Middle East and North Africa 0 0 Grantmaking 19662 Middle East and North Africa 0 0 Prog. Service Consulting 30500 North America 0 0 Grantmaking North America 0 0 Prog. Service Advertising 21500 North America 0 0 Prog. Service Consulting 64018 North America 0 0 Prog. Service Travel Reim. 1765 North America 0 0 Prog. Service Conference 110 North America 0 0 Prog. Service Supplies 495 Russia and the Newly Independent States 0 0 Prog. Service Conference 618 Russia and the Newly Independent States 0 0 Prog. Service Travel Reim. 901 South America 0 0 Prog. Service Consulting 238345 South America 0 0 Prog. Service Travel Reim. 704 South America 0 0 Prog. Service Conference 2090 South Asia 0 0 Grantmaking 16950 South Asia 0 0 Prog. Service Consulting 26639 South Asia 0 0 Prog. Service Conference 8134 South Asia 0 0 Prog. Service Travel Reim. 2102 Sub-Saharan Africa 0 0 Grantmaking 340581 Sub-Saharan Africa 0 0 Prog. Service Consulting 291704 Sub-Saharan Africa 0 0 Prog. Service Travel Reim. 8787 Sub-Saharan Africa 0 0 Prog. Service Conference 2260 Sub-Saharan Africa 0 0 Prog. Service Equipment, Repairs 5500 Sub-Saharan Africa 0 0 Prog. Service Dues 500 0 0 6573785 X East Asia and the Pacific Combating Dengue Fever in Indonesia - Phase II 81682 05GSumilarv 1,760 kg insect growth regulator Cost Europe Strengthing Surveillance Response in Central Africa (Gates) 1501244 Wire Transfer Europe Freedom from Smoking Initiative 1543525 Wire Transfer Europe Freedom from Smoking Initiative 47765 110 IPAQ 210 hand helds and AC Adapters cost Europe Freedom from Smoking Initiative 65766 Wire Transfer Europe Freedom from Smoking Initiative 64800 Wire Transfer Europe Freedom from Smoking Initiative 1356000 Wire Transfer Europe Freedom from Smoking Initiative 33900 Wire Transfer Europe Freedom from Smoking Initiative 25352 Wire Transfer Europe Freedom from Smoking Initiative 38447 Wire Transfer Middle East and North Africa Freedom from Smoking Initiative 8362 Wire Transfer Middle East and North Africa Freedom from Smoking Initiative 11300 Wire Transfer South Asia Freedom from Smoking Initiative 16950 Wire Transfer Sub-Saharan Africa Spinkles in Kenya 15542 Wire Transfer Sub-Saharan Africa Tuberculosis Trials Consortium Study 9516 Wire Transfer Sub-Saharan Africa Tuberculosis Trials Consortium Study 12164 Wire Transfer Sub-Saharan Africa Tuberculosis Trials Consortium Study 12164 Wire Transfer Sub-Saharan Africa Freedom from Smoking Initiative 282500 Wire Transfer East Asia and the Pacific Mobilizing CDC's Global Health Force 82666 Sub-Saharan Africa Global Health Wire Transfer 5500 Sub-Saharan Africa Louise Martin - Memorial Scholarship 3195 Wire Transfer 18 3 Schedule F, Part IV Other Information The CDC Foundation monitors grant funds in many ways. All programs are implemented in collaboration with the Centers for Disease Control and Prevention, an agency of the Federal Government. The CDC works closely with Foundation personnel to actively monitor the grantees progress and expenditures, and both the grantee and the CDC provide detailed information to the CDC Foundation's program officers who are assigned to the project. Often, the Foundation program officer will make site visits to ensure that the program is proceeding as agreed and that the funds are properly spent. All foreign payees are checked against the Treasury's Specially Designated Nationals List before disbursement is made. 1 Alabama Coalition Against Domestic Violence P O Box 4762 Montgomery AL 36103 630907890 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Alaska Native Tribal Health Concortium 4141 Ambassador Drive Anchorage AK 99508 920162721 501 (c)(3) 30000 Chronic Hepatitis B and C Cohort Study Case Western Reserve University 10900 Euclid Avenue Cleveland OH 441064984 341018992 501 (c)(3) 27760 Treatment of Tuberculosis with Priftin Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 7087 Cost Monitors, GPS Units, and Data Loggers Bed Nets Study - Togo Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 4990 Cost Brochures, lanyards CDC Visitor/Education Center Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 196 Cost Equipment repair Combating Dengue Fever in Indonesia Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 62500 Cost Blackberry devices Emergency Preparedness and Response Fund Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 151546 Cost IPAQ devices and adaptors, flashdrives, software, folders, book covers and t Freedom from Smoking Initiative Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 6299 Cost Flashlights and t-shirts HCV Education Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 53394 Cost FAST license and exchange license Mobile Surveillance for the Hajj - Saudi Arabia Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 6561 Cost Pulmonary hardware, pleythmograph, nebulizers Nasal aerosal delivery of influenza VLP vaccines Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 1296 Cost DVDs National Campaign Appropriate Antibiotic - Get Smart Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 27344 Cost Brochures, factsheets, and flashdrives National Initiative to Address MRSA in Healthcare Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 4736 Cost Flashdrives Preventing Infections in Cancer Patients Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 14477 Cost Generator and equipment repair Testosterone Measurement Harmonization Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 74052 Addressing Sexual Violence Against Girls Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 42742 CDC Experience Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 20000 Chronic Hepatitus B and C Cohort Study Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 1070 Combating Dengue Fever in Indonesia Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 712 Early Assessment Childhood Obesity Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 960 Emergency Preparedness and Response Fund Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 15138 Environmental Legionella Recovery Proficiency Testing Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 9333 Evaluation Resources for Health-related Nonprofits Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 1157318 Freedom from Smoking Initiative Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 83497 Global Disaster Response Fund Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 66000 Immune-Potentiation of Pneumococcal Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 14190 Improving Approaches to Breast Cancer Screening and Treatment Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 5656 Inflammatory Back Pain and Spondyloarthritis Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 436191 Innovative Uses of Technology in Existing Child Abuse Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 167650 Joint Global Field Epidemiology & Laboratory Training Program Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 73678 Kemri Vehicle Purchase Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 46000 Measles and Polio Vaccination Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 32164 Meta-Leadership Summits Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 405618 Meta-Leadership Summits Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 185950 Mobile Surveillance for the Hajj - Saudi Arabia Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 119410 MRSA Surveillance- Supplemental Evaluations Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 5051 Nasal aerosal delivery of influenza VLP vaccines Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 50000 Next Generation Vaccines for Hepatitis Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 36000 O.C. Hubert International Fellowship Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 55095 Oregon NHANES Study Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 309 Phones 4 Health Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 827 Phones for Health: PEPFAR Supported Countries Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 280 Preventing Infections in Cancer Patients Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 26300 Public Health Program Specialist Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 50000 RBL Proteins and Malaria Vaccines Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 36634 Reverse Vaccinology for Neisseria Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 50000 Schistosomiasis Vaccine Development Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 827940 Strengthing Survelliance Response in Central Africa Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 203086 Study of Inhibitors In Hemophilia Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 22482 Trypanosoma cruzi Mouse Screening Study Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 50000 Vaccine Developmnet for Novel H1N1 Influenza Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 5053 Viral Hepatitis Action Coalition (VHAC) Centers for Disease Control & Prevention 1600 Clifton Road Atlanta GA 30333 586051157 Govt 48700 Viral Variants for Rabies Research and Interventions Comprehensive Bleeding Disorders Center 4727 N Sheridan Road Peoria IL 61614 371361264 501 (c)(3) 40956 Study of Inhibitors In Hemophilia Connecticut Coalition Against Domestic Violence 90 Pitkin Street East Hartford CT 06108 060985675 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence DC Coalition Against Domestic Violence 5 Thomas Circle NW Washington DC 20005 521515600 501 (c)(3) 23000 National Initiative to Address MRSA in Healthcare Emory University 1599 Clifton Road Atlanta GA 30322 580566256 501 (c)(3) 2400 Atlanta Int'l Health Fellowship Emory University 1599 Clifton Road Atlanta GA 30322 580566256 501 (c)(3) 3378 Study of Inhibitors In Hemophilia Foundation for NIH 9650 Rockville Pike Bethesda MD 20814 521986675 501 (c)(3) 25000 Phones for Health: PEPFAR Supported Countries Grant Accounting Office University of Iowa B5 Jessup Hall Iowa City IA 52242 426004813 501 (c)(3) 33552 Study of Inhibitors In Hemophilia Harvard University PO Box 415649 Boston MA 022415649 042103580 501 (c)(3) 55040 Meta-Leadership Summits Henry Ford Health System One Ford Place Suite 3A Detroit MI 48202 381357020 501 (c)(3) 534325 Chronic Hepatitis B and C Cohort Study Idaho Coalition Against Sexual & Domestic Violence Inc 300 E Mallard Drive Suite 130 Boise ID 83706 820410899 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Indiana Coalition Against Domestic Violence 1915 West 18th Street Suite B Indianapolis IN 46202 311009769 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Indiana Hemophilia and Thrombosic Center Inc 8402 Harourt Rd Suite 500 Indianapolis IN 46260 352047838 501 (c)(3) 33552 Training in Bleeding Disorders for Healthcare Providers Iowa Coalition Against Domestic Violence 515 28th Street Des Moines IA 50312 421285094 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Jane Doe Inc The Massachusetts Coalition Against SA & DV 14 Beacon Street Suite 507 Boston MA 02108 042676138 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Kentucky Domestic Violence Association 111 Darby Shire Circle PO Box 356 Frankfort KY 40602 611110432 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Minnesota Coalition for Battered Women 590 Park Street Suite 410 St Paul MN 55103 411381433 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Missouri Coalition Against Domestic and Sexual Violence 217 Oscar Drive Suite A Jefferson City MO 65101 431479799 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Nebraska Domestic Violence Sexual Assault Coalition Inc 1000 O Street Suite 102 Lincoln NE 68508 470606289 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence New England Hemophilia Center UMass Memorial Hospital 119 Belmont Street Worcester MA 01605 043167352 501 (c)(3) 1689 Study of Inhibitors In Hemophilia New Hampshire Coalition Against Domestic Violence PO Box 353 Concord NH 033020353 020360151 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence New Jersey Coalition for Battered Women 1670 Whitehorse-Hamilton Sq Rd Trenton NJ 08690 222370010 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence NorthShore University HealthSystem 1001 University Place Evanston IL 60201 362167060 501 (c)(3) 38500 12 Step - Phase II Oklahoma Coalition Against Domestic Violence 3815 N Santa Fe Ave Suite 124 Oklahoma City OK 73118 731131211 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Oregon Coalition Against Domestic and Sexual Violence 380 SE Spokane Street Suite 100 Portland OR 97202 930739389 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Pan American Health and Education Foundation 525 23rd Street NW Washington DC 20037 237072046 501 (c)(3) 36817 Cost IPAQ devices, cases, adaptors and stylus kits Freedom from Smoking Initiative Pennsylvania Coalition Against Domestic Violence 6400 Flank Drive Suite 1300 Harrisburg PA 171122778 232052886 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence South Carolina Coalition Against Domestic Violence & Sexual Assault PO Box 7776 Columbia SC 29202 570760811 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence The Children's Mercy Hospital 2401 Gilham Road Kansas City MO 64108 440605373 501 (c)(3) 16497 Study of Inhibitors In Hemophilia The Regents of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501 (c)(3) 79490 12 Step - Phase II The Regents of the University of Michigan 3003 S State Street Ann Arbor MI 48109 386006309 501 (c)(3) 10782 Study of Inhibitors In Hemophilia The Texas Council on Family Violence Inc PO Box 26219 Austin TX 78716 742848462 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence United Nations Foundation 1800 Massachusetts Avenue NW Washington DC 20036 582368165 501 (c)(3) 93364 Phones for Health: PEPFAR Supported Countries University of Colorado Denver Hemophilia & Thrombosis 13001 E 17th Place Bldg 500 PO Box 6507 Aurora CO 80045 846000555 501 (c)(3) 34677 Study of Inhibitors In Hemophilia University of Massachusetts Medical School 55 Lake Avenue North Worcester MA 01655 043167352 501 (c)(3) 31863 Study of Inhibitors in Hemophilia Vanderbilt University Medical Center VU Station B Box 356310 Nashville TN 372356310 620476822 501 (c)(3) 16497 Study of Inhibitors In Hemophilia Virginia Commonwealth University Grants and Contracts P O Box 843039 Richmond VA 232843039 540757884 501 (c)(3) 33552 Study of Inhibitors In Hemophilia Washington State Coalition Against Domestic Violence 711 Capitol Way 702 Olympia WA 98501 911507028 501 (c)(3) 23000 Integrating Prevention Strategies into Organizations - Intimate Partner Violence Partners in Health 888 Commonwealth Avenue 3rd floor Boston MA 02215 043567502 501 (c)(3) 5000 Haiti relief 32 0 Procedure for Monitoring Grants in the U.S.: Part I, Line 2: Schedule I, Part I, Line 2: The CDC Foundation monitors grant funds in many ways. All programs are implemented in collaboration with the Centers for Disease Control and Prevention, an agency of the Federal Government. The CDC works closely with Foundation personnel to actively monitor the grantees progress and expenditures, and both the grantee and the CDC provide detailed information to the CDC Foundation's program officers who are assigned to the project. Often, the Foundation program officer will make site visits to ensure that the program is proceeding as agreed and that the funds are properly spent. X X X 0 0 0 0 0 0 0 0 0 Charles Stokes 256427 0 0 0 0 0 28924 0 24376 0 309727 0 0 0 Chloe Tonney 167967 0 0 0 0 0 19796 0 5704 0 193467 0 0 0 Supplemental Information Part III 3. The Foundation follows IRS prescribed procedures for establishing a rebuttable presumption of reasonableness of all compensation paid to "disqualfied persons" (as detailed in Section 4958 of The Internal Revenue Code of 1986) The Foundation hires an independent, international human resources firm to provide market data for all staff positions. This firm uses a variety of surveys and using these and their expertise, it recommends market values and salary ranges for staff positions. The Executive Committee of the Foundation which is comprised of the Chair, Treasurer, Secretary, and the Chairs of the Advancement and Nominating Committees are independent, voting members of the Board of Directors. The Committee reviews the data, evaluates the performance of the President/CEO and votes on his and the CFO's compensation. These actions are documented in accordance with the regulations under Section 4958 of the Code. X Electronics 2 48831 Fair Market Value X Electronics 3 63499 Fair Market Value 0 0 0 Form 990, Part VI, Section B, line 11 The Form 990 was prepared by the Foundation's public accounting firm in conjunction with key accounting staff of CDC Foundation. Subsequently, the Form 990 was reviewed by the Finance Committee of the Board of Directors and by legal counsel. Prior to electronic filing, key accounting staff reviewed the Form 990 with the Foundation's CEO/President. In addition, the Form 990 was sent to the Board of Directors for their review, comments, and questions. Form 990, Part VI, Section B, line 12c All members of the Board and all senior staff are required to sign the conflict of interest policy annually. The Foundation maintains a copy of the signature indicating compliance with the rules. Legal counsel reviews the policy annually with all Board members. Form 990, Part VI, Section B, line 15 An independent, international human resources consulting firm is provided with all position descriptions and that firm prepares a salary study including market values for each position and ranges for every grade. The Executive Committee of the Board, consisting of the Chair, Treasurer, Secretary, Nominating Chair, and Advancement Chair are provided with the information from the consultant. This Committee reviews the performance of the President/CEO, sets goals and objectives for the following year and determines the President's compensation package for the following year. Based upon the review of the CFO by the President, the Executive Committee also sets the compensation package of the CFO for the following year. Form 990, Part VI, Section C, line 18 The Foundation posts the prior three years of 990's and Form 1023 on its website. Form 990, Part VI, Section C, line 19 The Foundation posts the prior three years of audits on its website. Governing documents and the conflict of interest policy are not made public. Form 990, Part VI, Section B, Line 14 Document retention policy The Foundation has document retention and destruction policies, but they have not yet been approved by the Board. Form 990, Part IX, Line 11 (g) Fees for services The Foundation, working in concert with the CDC, spends the vast majority of its funds directly for programs and projects that further its exempt purposes. These disbursements are either in the form of grants or awards or in the form of fees for services. Fees for services range from translator fees for the tobacco surveys in fourteen countries, to consultants for the production of environmental scans, survey and statistical work, training manuals and research planning. The authority of the Foundation to pay for these services is addressed in the federal statute creating the Foundation and plays a vital role in helping CDC accomplish its mission. The Foundation monitors these fees and services to ensure that the amounts paid are reasonable and that program goals are being met. Form 990, Part X, Line 9 Prepaid expenses Although not a usual practice, the Foundation agreed to prepay an organization for personnel services to be provided during the current fiscal year. This arrangement was made due to the legal requirements of the provider and based upon their history of providing exceptional performance. This explains the significant variance in prepaid expenses year over year.